| Business

Become a contributor

Bookmark Econotimes

| Business

Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio

Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market

Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio

Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector

Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares

California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage

JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026

Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance

Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies

Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown

Italy Fines Apple €98.6 Million Over App Store Dominance

Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue

BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands

South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge

ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants

Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling

Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift

©Econometrics LLC . All Rights Reserved.

Nasdaq Halts Kitov Pharmaceuticals Holdings Ltd.

Tuesday, February 7, 2017 3:08 PM UTC

NEW YORK, Feb. 07, 2017 -- The Nasdaq Stock Market^® (Nasdaq:NDAQ) announced that trading was halted today in Kitov Pharmaceuticals Holdings Ltd. (Nasdaq:KTOV), (Nasdaq:KTOVW) at 09:22:28 Eastern Time for "additional information requested" from the company at a last sale price of $2.55 and $0.89 respectively.

Trading will remain halted until Kitov Pharmaceuticals Holdings Ltd. has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotes^SMon the Nasdaq^® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:
Peter Gau
+1.212.231.5475
[email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Market Data

BOJ Governor Signals Gradual Rate Hikes as Japan’s Inflation Nears 2% Target

Christmas Eve Jazz Concert Canceled After Kennedy Center Renaming to Include Trump

U.S. Prioritizes Economic Pressure With Venezuelan Oil Quarantine as Sanctions Intensify

Taiwan Stock Market Ends Higher as Semiconductor and Energy Shares Lead Gains

Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy

Zelenskiy Discusses Ukraine Peace Efforts With Trump Envoys

Russian Stocks End Lower as Energy and Mining Shares Weigh on MOEX Index

U.S. Judge Blocks Deportation of British Anti-Disinformation Campaigner Imran Ahmed Amid Free Speech Dispute

Bolsonaro Endorses Son Flavio for Brazil’s 2026 Presidential Election From Hospital

EconoTimes

Disclaimer: EconoTimes provides references and links to selected blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the blogs or other sources of information. Clients and prospects are advised to carefully consider the opinions and analysis offered in the blogs or other information sources in the context of the client or prospect's individual analysis and decision making. None of the blogs or other sources of information is to be considered as constituting a track record. Past performance is no guarantee of future results and EconoTimes specifically advises clients and prospects to carefully review all claims and representations made by advisors, bloggers, money managers and system vendors before investing any funds or opening an account with any Brokerage. Any news, opinions, research, data, or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. EconoTimes expressly disclaims any liability for any lost principal or profits without limitation which may arise directly or indirectly from the use of or reliance on such information. As with all such advisory services, past results are never a guarantee of future results.

Nasdaq Halts Kitov Pharmaceuticals Holdings Ltd.

Editor's Picks

Welcome to EconoTimes